Results 211 to 220 of about 183,086 (327)

Searching for a Needle in a Haystack: Chemical Analysis Reveals Nitazenes Found in Drug Paraphernalia Residues

open access: yesDrug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Introduction A group of synthetic opioids, the nitazenes, is appearing in the illicit drug market. Monitoring these novel psychoactive substances is challenging due to constantly evolving analogues and the small amounts of these potent drugs that are consumed.
Emma L. Keller   +6 more
wiley   +1 more source

Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids

open access: yesDrug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Introduction The global drug market has seen an emergence of potent synthetic opioids, including benzimidazole‐derived substances known as nitazenes. These compounds have been implicated in fatal and non‐fatal overdoses. This review aims to synthesise current evidence on the pharmacological effects, potency and naloxone responsiveness of new ...
Suzanne Nielsen   +8 more
wiley   +1 more source

Is Addiction Research Addicted to Artificial Intelligence? Mapping the Intersection of Artificial Intelligence, Substance Use and Mental Health Through a Bibliometric Analysis

open access: yesDrug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Issues From extracting insights from large‐scale, multimodal data to prevention and support, there is growing interest in the applications and implications of recent advances in Artificial Intelligence (AI) within the fields of addiction, substance use and mental health, which we refer to as ASUM.
Loïs Vanhée, Simone Scarpa
wiley   +1 more source

Community Pharmacy‐Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program

open access: yesDrug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Introduction Access to evidence‐based treatment for opioid use disorder remains limited, particularly for individuals who have not responded to oral opioid agonist treatment (OAT). A community pharmacy‐based model of injectable OAT (iOAT) was piloted in Vancouver, Canada from March 2017 to December 2018. This brief report describes the program
Tamara Mihic   +7 more
wiley   +1 more source

Effectiveness of Psychosocial Interventions for Adults With Substance Use Disorder That Have a Co‐Occurring Common Mental Health Disorder: An Umbrella Review

open access: yesDrug and Alcohol Review, Volume 45, Issue 1, January 2026.
ABSTRACT Issues People with substance use disorders can have co‐occurring mental disorders. Approach An umbrella review was conducted to identify evidence of the effectiveness of psychosocial interventions for adults (aged 18+) with substance use disorders and co‐occurring common mental health disorders.
Emma L. Simpson   +4 more
wiley   +1 more source

Prophylactic administration of metformin alleviates withdrawal symptoms associated with heroin. [PDF]

open access: yesFront Pharmacol
Liu M   +10 more
europepmc   +1 more source

Effect of heroin on right ventricular cardiac performance

open access: green, 2020
Murat Selcuk   +4 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy